+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 12Years - 70Years
All Genders
ID07791849

Comparing Proton Pump Inhibitors and Gastric Protective Agents to Prevent Acute Graft-versus-Host Disease After Stem Cell Transplant

Led by First Affiliated Hospital of Zhejiang University · Updated on 2026-08-28

198

Participants Needed

1

Research Sites

15 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how different stomach protection methods affect the risk of acute graft-versus-host disease aGVHD in patients undergoing allogeneic hematopoietic stem cell transplantation allo-HSCT. This trial compares the routine use of proton pump inhibitors PPIs, which may change gut bacteria and increase aGVHD risk, with teprenone, a drug that protects the stomach lining without reducing stomach acid. The study aims to see if switching from PPIs to teprenone after transplantation lowers aGVHD rates and related complications. Participants are randomly assigned to one of two groups one group receives standard-dose PPIs during conditioning and switches to teprenone after transplant through day 100 the other group continues PPIs from conditioning through day 100. Probiotics are not allowed during this period. Both groups receive the same anti-infective and graft-versus-host disease prevention treatments alongside their assigned stomach protection therapy. During the study, participants will follow their assigned stomach protection treatment and undergo regular checks for safety and effectiveness, including monitoring for aGVHD and infections. They will provide stool, saliva, and blood samples at several points before and after transplantation to analyze gut and oral microbiomes and other biological markers. Participants will be followed for one year to assess health outcomes, including aGVHD incidence, infections, and survival.

CONDITIONS

Brief Title

GMPA Versus PPI for Gastric Protection and aGVHD Risk

Research Team

F

Fei Gao

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here